WallStSmart

Medtronic PLC (MDT)vsMeta Platforms Inc. (META)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Meta Platforms Inc. generates 506% more annual revenue ($214.96B vs $35.48B). META leads profitability with a 32.8% profit margin vs 13.0%. META appears more attractively valued with a PEG of 0.93. META earns a higher WallStSmart Score of 83/100 (A-).

MDT

Buy

58

out of 100

Grade: C

Growth: 4.0Profit: 6.5Value: 6.7Quality: 5.0

META

Exceptional Buy

83

out of 100

Grade: A-

Growth: 9.3Profit: 10.0Value: 8.0Quality: 7.0
Piotroski: 3/9Altman Z: 2.88
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDTUndervalued (+27.7%)

Margin of Safety

+27.7%

Fair Value

$107.79

Current Price

$76.15

$31.64 discount

UndervaluedFair: $107.79Overvalued
METAUndervalued (+33.9%)

Margin of Safety

+33.9%

Fair Value

$933.07

Current Price

$609.63

$323.44 discount

UndervaluedFair: $933.07Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$100.09B9/10

Large-cap with strong market position

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$2.30B8/10

Generating 2.3B in free cash flow

META6 strengths · Avg: 10.0/10
Market CapQuality
$1.57T10/10

Mega-cap, among the largest globally

Return on EquityProfitability
32.9%10/10

Every $100 of equity generates 33 in profit

Profit MarginProfitability
32.8%10/10

Keeps 33 of every $100 in revenue as profit

Operating MarginProfitability
40.6%10/10

Strong operational efficiency at 40.6%

Revenue GrowthGrowth
33.1%10/10

Revenue surging 33.1% year-over-year

EPS GrowthGrowth
62.4%10/10

Earnings expanding 62.4% YoY

Areas to Watch

MDT1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-11.8%2/10

Earnings declined 11.8%

META1 concerns · Avg: 3.0/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin. PEG of 1.36 suggests the stock is reasonably priced for its growth.

Bull Case : META

The strongest argument for META centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 32.8% and operating margin at 40.6%. Revenue growth of 33.1% demonstrates continued momentum.

Bear Case : MDT

The primary concerns for MDT are EPS Growth.

Bear Case : META

The primary concerns for META are Piotroski F-Score.

Key Dynamics to Monitor

MDT profiles as a value stock while META is a growth play — different risk/reward profiles.

META carries more volatility with a beta of 1.24 — expect wider price swings.

META is growing revenue faster at 33.1% — sustainability is the question.

META generates stronger free cash flow (13.2B), providing more financial flexibility.

Bottom Line

META scores higher overall (83/100 vs 58/100), backed by strong 32.8% margins and 33.1% revenue growth. MDT offers better value entry with a 27.7% margin of safety. Both earn "Exceptional Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

Meta Platforms Inc.

COMMUNICATION SERVICES · INTERNET CONTENT & INFORMATION · USA

Meta Platforms, Inc. develops products that enable people to connect and share with friends and family through mobile devices, PCs, virtual reality headsets, wearables and home devices around the world. The company is headquartered in Menlo Park, California.

Visit Website →

Want to dig deeper into these stocks?